EUFETS Becomes BioNTech Innovative Manufacturing Services


BioNTech AG, announced on October 1st, 2017 that its manufacturing subsidiary EUFETS GmbH has been re-branded BioNTech Innovative Manufacturing Services.


BioNTech Innovative Manufacturing Services (BioNTech IMFS), based in Idar-Oberstein, Germany, is one of the most experienced GMP-certified contract development and manufacturing organizations worldwide, specialized in the industrialization of cell and gene therapy products such as viral vectors, cellular products and in vitro transcribed mRNA. For over 20 years, it has supplied important cell and gene therapy medicinal products worldwide and will continue to support Third Parties with its services.